Market Currents
JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous...
-
Tuesday, September 18, 2012, 5:26 PM ETJNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous formulation for the treatment of adults with moderately to severely active rheumatoid arthritis.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
